WINDSOR JAMES BRIAN 4
4 · Aileron Therapeutics, Inc. · Filed Dec 9, 2024
Insider Transaction Report
Form 4
WINDSOR JAMES BRIAN
President and COO
Transactions
- Purchase
Common Stock
2024-12-05$2.24/sh+239$535→ 239 total(indirect: By son) - Purchase
Common Stock
2024-12-05$2.25/sh+161$362→ 161 total(indirect: By son)
Holdings
- 7,122
Common Stock
- 225(indirect: By son)
Common Stock
Footnotes (1)
- [F1]The reporting person disclaims beneficial ownership of all securities held by his son, and this report should not be deemed an admission that the reporting person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.